EP4176894
Þáttar VIII blendingsprótín og notkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.1.2015EP published:
28.2.2024EP application number:
22181403.1
EP translation filed:
13.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
8.1.2035Expiry date:
8.1.2027Next due date:
31.1.2027
Title in English:
FACTOR VIII CHIMERIC PROTEINS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
9.1.2015EP application
28.2.2024EP Publication
13.5.2024Translation submitted
15.6.2024Registration published
8.1.2027Expires
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham MA 02451, US
Inventor
Name:
CHHABRA, Ekta, SethAddress:
Framingham, MA 01702, US
Name:
LIU, TongyaoAddress:
Lexington, MA 02421, US
Name:
PETERS, Robert T.Address:
Needham, MA 02492, US
Name:
KULMAN, JohnAddress:
Belmont, MA 02748, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461926226 PDate:
10.1.2014Country:
US
Number:
201461988104 PDate:
2.5.2014Country:
US
Supplementary protection
SPC number:
SPC499
Classification
Categories:
A61K 38/36
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 10.12.2024
Expires: 8.1.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.1.2026
Expires: 8.1.2027
Payer: Árnason Faktor ehf.